SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs >

OncoVista Innovative Therapies, Inc. (OVIT)

OVIT RSS Feed
Add OVIT Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/18/2017 5:41:35 PM - Followers: 17 - Board type: Free - Posts Today: 0

OncoVista Innovative Therapies, Inc. (OVIT) 

 

Please see the bottom of the iBox for a contrary view on this stock.

 

http://www.oncovista.com/

 

 

Company Information:

OncoVista Innovative Therapies, Inc.
14785 Omicron Drive
Suite 104
San Antonio,, TX 78245

Phone: 210-677-6000

 

CIK:  0001094847

The latest 10Q can be found here: http://filings.issuerdirect.com/data/1094847/000114420411063209/v240119_10q.pdf

Link to clinical trials register: http://www.clinicaltrials.gov/ct2/results?term=cordycepin 

Neither of the two cordycepin studies registered with clinical.trials.gov has been updated for over two years, which is a breach of registration conditions.

 

 

OncoVista Innovative Therapies, Inc., is a bio-pharmaceutical company that claims to be dedicated to providing innovative, safe and efficacious treatments for cancer through the use of biomarkers in order to extend and improve the quality of life for patients.

Based in San Antonio, Texas, OncoVista was incorporated in 2004 and says it utilizes state-of-the-art drug discovery technologies, innovative clinical development and registration strategies as well as emerging technologies to bring to market new, safe and highly effective anti-cancer drugs. Although no such drugs have yet been brought to market, and the "incubator" behind Onco Vista, Technology Innovations, LLC, has a long and inglorious history of transferring monies from its publicly held spin-offs such as Biophan and Natural Nano into private hands.

 

Management: 

http://www.oncovista.com/index.php?option=com_content&task=view&id=67

 

 

Claims made by Onco Vista regarding its Core Capabilities for Accelerated Drug Development

Lipitek International
Well-equipped research labs for chemical synthesis and biological evaluations; GMP manufacturing suite

UT Health Science Center (Prof. Luduena)
Biological evaluation and testing of new anti-mitotics, including tubulin isotype-specific assays

University of Alberta (Prof. Tuszynski)
Molecular modeling, computer simulation of new molecules, molecule design and in silico screening

AAI Oncology (Paris)
Global oncology-focused clinical Contract Research Organization (CRO)

Cancer Therapy & Research Center (CTRC)/Institute for Drug Development (IDD)
In vitro and in vivo capabilities; Phase I/II clinical trials

Other Local Resources (nothing to do with Onco Vista per se: probably included here to give an impression of referred respectability).
Southwest Oncology Group
Southwest Foundation for Biomedical Research

 

 

 

Press Releases:  
http://www.oncovista.com/index.php?option=com_content&task=view&id=91

http://finance.yahoo.com/q/h?s=OVIT.OB+Headlines

 

 

-----------------------

 

 

 

AdnaGen

http://www.adnagen.com/

 

News from AdnaGen site, which is majority owned by OVIT

http://www.adnagen.com/HTML_Dateien/e_news_news.htm

 

OVIT used to own 78% of the issued and outstanding shares of AdnaGen*

 

* On November 2, 2010, OncoVista Innovative Therapies, Inc. (the "Company") entered into a Stock Purchase Agreement with Alere Holdings Bermuda Limited Canon's Court ("Alere Holdings"), whereby the Company sold all of its shares, representing approximately 78.01% of the total issued and outstanding shares, of its majority-owned German operating subsidiary AdnaGen AG ("AdnaGen").   Under the terms of the Stock Purchase Agreement, the Company and the other AdnaGen shareholders agreed to sell their respective shares of AdnaGen, and all AdnaGen related business assets, to Alere Holdings in consideration of: (i) a $10,000,000 up-front;  (ii) $10,000,000 in potential milestone payments contingent upon the achievement of various balance sheet objectives within 24 months; and (iii) up to $63,000,000 in potential milestone payments contingent upon the achievement of various clinical, regulatory and sales objectives within 36 months (collectively, the "Consideration").  The Company is entitled to receive its pro rata portion of approximately 78.01% of all Consideration.http://www.sec.gov/Archives/edgar/data/1094847/000114420410057309/v200923_8k.htm

 

----------------------

  

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001094847&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 

Share Structure:

Authorized Shares

147,397,390 as of September 30, 2011

 

Outstanding Shares

21,370,725 as of September 30, 2011

 

Investor Relations:

Aimee Boutcher

973-239-2878

aboutcher@aol.com

 

 

 


 

 


 

 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Also, keep in mind that moderators may or may not have a position in said stock. 

Being a moderator isn't a sign of endorsement. In fact, the current Mod thinks that the founders of TI, the LLC company behind OVIT (and NNAN and BIPH), are practising crooks.

 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:
http://investorshub.advfn.com/boards/complex_terms.asp

 

SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
OVIT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#359   stop and think. there is only ONE way biotech2 09/18/17 05:41:35 PM
#358   How do you know this exactly? Witty159 09/18/17 05:19:07 PM
#357   was that you nibbling ? congrats biotech2 09/18/17 04:01:00 PM
#356   congrats on your purchase biotech2 09/18/17 03:58:38 PM
#355   All that is almost impossible to guess, BUT biotech2 09/16/17 10:10:49 PM
#354   Thank you, so in your opinion, after a gi197845 09/16/17 09:52:10 PM
#353   They would change the name after the merger. biotech2 09/16/17 09:48:58 PM
#352   Biotech2, why would another biotech need OVITs shell? gi197845 09/16/17 09:06:36 PM
#351   you are missing the whole point. There is biotech2 09/16/17 08:40:20 PM
#350   Why would any other biotech/pharma want to allow gi197845 09/16/17 12:42:18 PM
#349   Agree with opportunity, could EASILY be 100 times biotech2 09/16/17 09:33:37 AM
#348   litigation was resolved, and a judgement was issued. biotech2 09/16/17 09:22:14 AM
#347   You are speaking of the Camofi case I sharkgroupsn 09/16/17 08:14:11 AM
#346   The lawsuit against OVIT was settled in a gi197845 09/15/17 11:06:12 PM
#345   You do realize that Oncovista is involved in sharkgroupsn 09/15/17 06:51:29 PM
#344   OVIT is a shell, nothing else, I biotech2 09/15/17 05:07:35 PM
#343   Biotech2, what makes you think Weis is refusing gi197845 09/15/17 03:30:06 PM
#342   If you know him, tell him that he biotech2 09/14/17 07:47:04 AM
#341   WEIS is fine. Active. sharkgroupsn 09/12/17 05:01:47 PM
#340   IS WEIS IN FAILING HEALTH ? THAT WILL biotech2 09/12/17 10:19:46 AM
#339   Down Close to 60 grand right now, but biotech2 09/10/17 01:55:59 PM
#338   How much underwater are you on OVIT, with gi197845 09/10/17 12:48:44 PM
#337   HOLDING 450,000 share position. A huge homerun or biotech2 09/05/17 01:13:55 PM
#336   very interesting, reverse merger won't be much longer biotech2 08/20/17 06:09:56 PM
#335   Current article involving Dr.Weis. gi197845 08/16/17 09:25:22 PM
#334   Dr.Weis and Hillary for prison. Or, will OVIT gi197845 08/16/17 09:19:13 PM
#333   Was the 15,000 volume on 8/16/17 buying or selling? gi197845 08/16/17 09:16:32 PM
#332   I'm betting on a reverse merger with brand biotech2 08/08/17 11:48:06 AM
#331   Thanks for the advice, but ovit lost ovi-123 gi197845 08/08/17 10:51:11 AM
#330   Then just buy what you can afford, IF biotech2 08/08/17 07:36:03 AM
#329   Ok then, why don't you loan my $3,000 gi197845 08/07/17 03:24:24 PM
#328   I know they are buying because I have biotech2 08/07/17 02:07:02 PM
#327   I am considering that as a possibility, but gi197845 08/07/17 01:44:05 PM
#326   ten why woulldnt you buy 100,000 shares for biotech2 08/07/17 01:39:38 PM
#325   I'm following ovit, because I got screwed with gi197845 08/07/17 01:38:05 PM
#324   understand your investment thesis, BUT why are you biotech2 08/07/17 01:20:38 PM
#323   Yes, this is what I meant...I sold all gi197845 08/07/17 11:39:45 AM
#322   Don't you mean OVIT instead of INNV ? biotech2 08/06/17 08:16:48 PM
#321   No, I sold all INNV and did not gi197845 08/06/17 01:33:43 PM
#320   did you buy back in after tax loss biotech2 08/05/17 10:10:36 PM
#319   Well, at least you admit it and at gi197845 08/01/17 03:50:51 PM
#318   Down many tens of thousands, dont even look biotech2 08/01/17 03:33:28 PM
#317   If that's the case, how many thousands of gi197845 08/01/17 02:47:14 PM
#316   no way, I ALREADY own way TOO many biotech2 08/01/17 02:10:50 PM
#315   Why don't you just admit that it's you buying? gi197845 08/01/17 01:57:02 PM
#314   people nibble, but dont buy much, cant blame biotech2 08/01/17 12:42:25 PM
#312   did that cause todays buyng ? biotech2 07/28/17 03:36:52 PM
#310   I sold long ago for a loss. They gi197845 07/27/17 12:46:54 PM
#309   Look at today's SP. It's a brain dead Batermere 07/27/17 12:34:02 PM
#308   Ok, I would have thought that OVIT would gi197845 07/27/17 12:17:44 PM
PostSubject